The Plasma Protein Therapeutics Association (PPTA) is a dynamic trade association that represents a unique sector of the biologics and biotechnology industry.
PPTA represents more than 650 human plasma collection centers in North America and Europe, as well as, the manufacturers of life-saving plasma protein therapies.
Our members produce approximately 80 percent of the plasma protein therapies in the U.S. and 60 percent of those manufactured in Europe.
PPTA works globally to:
- Advocate for access to and affordability of therapies for patients
- Engage in constructive dialogue with regulatory agencies
- Collaborate with more than 20 patient advocacy organizations
PPTA also administers standards programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.